KV Official Is Excluded From Government Programs, The First Under OIG's New Guidance

Former CEO Marc Hermelin resigns from KV's board to prevent the company's exclusion; KV dissolved Ethex under agreement with OIG.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet